Table 2.
Development of Multiple Myeloma or a Related Disorder in 64 Patients With MGUS
| Number (%)of patients | Interval to Disease (y) | ||
|---|---|---|---|
| Median | Range | ||
| Multiple myeloma | 44 (69) | 10.6 | 1–32 |
| Macroglobulinemia | 7 (11) | 10.3 | 4–16 |
| Amyloidosis | 8 (12) | 9.0 | 6–19 |
| Lymphoproliferative disease | 5 (8) | 8.0 | 4–19 |
| Total | 64 (100) | 10.4 | 1–32 |
a
The percentage was calculated as the number of patients with MGUS divided by the number who were tested.
b
Prevalence was age-adjusted to the 2000 US total population as follows: men, 4.0% (95% confidence interval, 3.5 to 4.4); women, 2.7% (95% confidence interval, 2.4 to 3.0); and total, 3.2% (95% confidence interval, 3.0 to 3.5).
c
Prevalence was age- and sex-adjusted to the 2000 US total population.
From Kyle RA et al. N Engl J Med. 2006.[XX] Copyright © 2006 by the Massachusetts Medical Society. All rights reserved.